ARALEZ PHARMACEUTICALS INC. Deferred Revenue Recognized
ARALEZ PHARMACEUTICALS INC. reported Deferred Revenue Recognized of $2.43 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. contract with customer, liability, revenue recognized for the quarter ending 2018-03-31 was $2.43M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month |
|---|---|
| 2018-03-31 | $2.43M 10-Q · filed 2018-05-08 |